???pagination.result.count???
???pagination.result.page???
1
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery. , O'Connor EC., Expert Opin Drug Discov. February 1, 2024; 19 (2): 173-187.
SLC12A ion transporter mutations in sporadic and familial human congenital hydrocephalus. , Jin SC., Mol Genet Genomic Med. September 1, 2019; 7 (9): e892.
Potassium-chloride cotransporter 3 interacts with Vav2 to synchronize the cell volume decrease response with cell protrusion dynamics. , Salin-Cantegrel A., PLoS One. May 15, 2013; 8 (5): e65294.
A trafficking-deficient mutant of KCC3 reveals dominant-negative effects on K-Cl cotransport function. , Ding J., PLoS One. January 1, 2013; 8 (4): e61112.
Transit defect of potassium-chloride Co-transporter 3 is a major pathogenic mechanism in hereditary motor and sensory neuropathy with agenesis of the corpus callosum. , Salin-Cantegrel A., J Biol Chem. August 12, 2011; 286 (32): 28456-65.
Distal truncation of KCC3 in non-French Canadian HMSN/ ACC families. , Salin-Cantegrel A., Neurology. September 25, 2007; 69 (13): 1350-5.
NH2-terminal heterogeneity in the KCC3 K+-Cl- cotransporter. , Mercado A., Am J Physiol Renal Physiol. December 1, 2005; 289 (6): F1246-61.
Ammonium transport and pH regulation by K(+)-Cl(-) cotransporters. , Bergeron MJ., Am J Physiol Renal Physiol. July 1, 2003; 285 (1): F68-78.